Appendix B: Sources of evidence considered by the Medical Technologies Advisory Committee

Appendix B: Sources of evidence considered by the Medical Technologies Advisory Committee

A The External Assessment Centre report for this assessment was prepared by the Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust:

  • Colechin E, Sims A, Reay C et al. Regional Medical Physics department, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust. Ambulight PDT (November 2010)

B Submissions from the following manufacturer/sponsor:

  • Ambicare Health Ltd

C The following individuals gave their expert personal view on Ambulight PDT for the treatment of non-melanoma skin cancer by providing their expert comments on the draft scope, assessment report and the medical technology consultation document.

  • Dr Sally Ibbotson, nominated/ratified by the British Association of Dermatologists – clinical expert

  • Dr Christopher Harland, nominated/ratified by the British Association of Dermatologists – clinical expert

D The following individuals gave their expert personal view on Ambulight PDT for the treatment of non-melanoma skin cancer in writing by completing a patient questionnaire or expert adviser questionnaire provided to the Committee.

  • Mr Paul Norris, nominated/ratified by the British Association of Dermatologists – clinical expert

  • Alison Layton, nominated/ratified by the British Association of Dermatologists – clinical expert

  • Victoria Goulden, nominated/ratified by the British Association of Dermatologists/British Photobiology group – clinical expert

  • Skin Care Campaign – patient comment

  • National Institute for Health and Care Excellence (NICE)